3'-HydroxyflavoneCAS# 70460-18-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 70460-18-3 | SDF | Download SDF |
PubChem ID | 229015 | Appearance | Powder |
Formula | C15H10O3 | M.Wt | 238.24 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-(3-hydroxyphenyl)chromen-4-one | ||
SMILES | C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC(=CC=C3)O | ||
Standard InChIKey | ISZWRZGKEWQACU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H10O3/c16-11-5-3-4-10(8-11)15-9-13(17)12-6-1-2-7-14(12)18-15/h1-9,16H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
3'-Hydroxyflavone Dilution Calculator
3'-Hydroxyflavone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.1974 mL | 20.9872 mL | 41.9745 mL | 83.949 mL | 104.9362 mL |
5 mM | 0.8395 mL | 4.1974 mL | 8.3949 mL | 16.7898 mL | 20.9872 mL |
10 mM | 0.4197 mL | 2.0987 mL | 4.1974 mL | 8.3949 mL | 10.4936 mL |
50 mM | 0.0839 mL | 0.4197 mL | 0.8395 mL | 1.679 mL | 2.0987 mL |
100 mM | 0.042 mL | 0.2099 mL | 0.4197 mL | 0.8395 mL | 1.0494 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (Rac)-Hesperetin
Catalog No.:BCN0325
CAS No.:69097-99-0
- Grindelic acid
Catalog No.:BCN0324
CAS No.:1438-57-9
- Fukinolic acid
Catalog No.:BCN0323
CAS No.:50982-40-6
- trans-Ferulic acid
Catalog No.:BCN0322
CAS No.:537-98-4
- Euphorbol
Catalog No.:BCN0321
CAS No.:566-14-3
- Ethyl trans-caffeate
Catalog No.:BCN0320
CAS No.:66648-50-8
- (+/-)-Eriodictyol
Catalog No.:BCN0319
CAS No.:4049-38-1
- Echinatine N-oxide
Catalog No.:BCN0318
CAS No.:20267-93-0
- Diosmetin 7-glucuronide
Catalog No.:BCN0317
CAS No.:35110-20-4
- 2',6'-Dihydroxy 4',4-dimethoxychalcone
Catalog No.:BCN0316
CAS No.:94441-99-3
- Dihydroavenanthramide D
Catalog No.:BCN0315
CAS No.:697235-49-7
- 23-epi-26-Deoxyactein
Catalog No.:BCN0314
CAS No.:501938-01-8
- Hyperforin (stable Dicyclohexylammonium salt)
Catalog No.:BCN0327
CAS No.:238074-03-8
- Isomenthone
Catalog No.:BCN0328
CAS No.:491-07-6
- Isoxanthohumol
Catalog No.:BCN0329
CAS No.:521-48-2
- Lactucin
Catalog No.:BCN0330
CAS No.:1891-29-8
- Lavandulol
Catalog No.:BCN0331
CAS No.:58461-27-1
- Lavandulyl acetate
Catalog No.:BCN0332
CAS No.:25905-14-0
- (+)-Lupanine hydrochloride
Catalog No.:BCN0333
CAS No.:1025-39-4
- 6-Methoxytricin
Catalog No.:BCN0334
CAS No.:76015-42-4
- 16-O-Methylcafestol
Catalog No.:BCN0335
CAS No.:108214-28-4
- Naringenin chalcone
Catalog No.:BCN0336
CAS No.:25515-46-2
- Pinocembroside
Catalog No.:BCN0337
CAS No.:75829-43-5
- (S)-4',5,7-Trihydroxy-6-prenylflavanone
Catalog No.:BCN0338
CAS No.:68682-01-9
Preference for O-demethylation reactions in the oxidation of 2'-, 3'-, and 4'-methoxyflavones by human cytochrome P450 enzymes.[Pubmed:32312164]
Xenobiotica. 2020 Oct;50(10):1158-1169.
2'-, 3'-, and 4'-Methoxyflavones (MeFs) were incubated with nine forms of recombinant human cytochrome P450 (P450 or CYP) enzymes in the presence of an NADPH-generating system and the products formed were analyzed with LC-MS/MS methods.CYP1B1.1 and 1B1.3 were highly active in demethylating 4'MeF to form 4'-hydroxyflavone (rate of 5.0 nmol/min/nmol P450) and further to 3',4'-dihydroxyflavone (rates of 2.1 and 0.66 nmol/min/nmol P450, respectively). 3'MeF was found to be oxidized by P450s to m/z 239 (M-14) products (presumably 3'-hydroxyflavone) and then to 3',4'-dihydroxyflavone. P450s also catalyzed oxidation of 2'MeF to m/z 239 (M-14) and m/z 255 (M-14, M-14 + 16) products, presumably mono- and di-hydroxylated products, respectively.At least two types of ring oxidation products having m/z 269 fragments were formed, although at slower rates than the formation of mono- and di-hydroxylated products, on incubation of these MeFs with P450s; one type was products oxidized at the C-ring, having m/z 121 fragments, and the other one was the products oxidized at the A-ring (having m/z 137 fragments).Molecular docking analysis indicated the preference of interaction of O-methoxy moiety of methoxyflavones in the active site of CYP1A2.These results suggest that 2'-, 3'-, and 4'-methoxyflavones are principally demethylated by human P450s to form mono- and di-hydroxyflavones and that direct oxidation occurs in these MeFs to form mono-hydroxylated products, oxidized at the A- or B-ring of MeF.
Biotransformations of Flavones and an Isoflavone (Daidzein) in Cultures of Entomopathogenic Filamentous Fungi.[Pubmed:29874813]
Molecules. 2018 Jun 5;23(6). pii: molecules23061356.
Entomopathogenic filamentous fungi of the genus Isaria are effective biocatalysts in the biotransformation of flavonoids as well as steroids. In the present study, the species Isariafumosorosea and Isariafarinosa isolated from the environment were used. Their catalytic capacity to carry out biotransformations of flavones-unsubstituted, with hydroxy- and amino-substituents as well as a hydroxylated isoflavone-was investigated. Biotransformations of flavone, 5-hydroxyflavone, 6-hydroxyflavone, 7-hydroxyflavone, and daidzein resulted in the formation of O-methylglucosides, in the case of flavone and 5-hydroxyflavone with additional hydroxylations. 7-Aminoflavone was transformed into two acetamido derivatives. The following products were obtained: From flavone(-)flavone 2'-O-beta-d-(4''-O-methyl)-glucopyranoside, flavone 4'-O-beta-d-(4''-O-methyl)-glucopyranoside and 3'-hydroxyflavone 4'-O-beta-d-(4''-O-methyl)-glucopyranoside; from 5-hydroxyflavone(-)5-hydroxyflavone 4'-O-beta-d-(4''-O-methyl)-glucopyranoside; from 6-hydroxyflavone(-)flavone 6-O-beta-d-(4''-O-methyl)-glucopyranoside; from 7-hydroxyflavone(-)flavone 7-O-beta-d-(4''-O-methyl)-glucopyranoside; from daidzein(-)daidzein 7-O-beta-d-(4''-O-methyl)-glucopyranoside; and from 7-aminoflavone(-)7-acetamidoflavone and 7-acetamido-4'-hydroxyflavone. Seven of the products obtained by us have not been previously reported in the literature.
Two new 5-deoxyflavonoids from Calliandra inermis.[Pubmed:15304993]
Chem Pharm Bull (Tokyo). 2004 Aug;52(8):974-5.
Two new 5-deoxyflavonoids, 7,2',3',4'-tetramethoxyflavone (1) and 7,2',3',4'-tetramethoxyflavanone (2) together with a known flavone 7,4'-dimethoxy-3'-hydroxyflavone (3) were isolated from the whole plant of Calliandra inermis. The structures of these new compounds were elucidated by high resolution electron impact mass spectrometry (HR-EI-MS) and 1D and 2D-NMR spectral studies including 1H-1H correlation spectroscopy (COSY), heteronuclear single quantum coherence (HSQC), heteronuclear multiple bond connectivity (HMBC) and nuclear Overhauser enhancement spectroscopy (NOESY).
Two new 5-deoxyflavones from Albizia odoratissima.[Pubmed:12237551]
Chem Pharm Bull (Tokyo). 2002 Sep;50(9):1271-2.
Two new 5-deoxyflavones, 7,8-dimethoxy-3',4'-methylenedioxyflavone (1) and 7,2',4'-trimethoxyflavone (2) together with a known flavone, 7,4'-dimethoxy-3'-hydroxyflavone (3) were isolated from the rootbark of Albizia odoratissima. The structures of these new compounds were elucidated by electrospray ionization mass spectrometry (ESI-MS) and 1D and 2D-NMR spectral studies including (1)H-(1)H correlation spectroscopy (COSY), heteronuclear single quantum coherence (HSQC), heteronuclear multiple bond connectivity (HMBC) and nuclear Overhauser enhancement spectroscopy (NOESY).
Anti-inflammatory activity of flavone and some of its derivates from Virola michelli Heckel.[Pubmed:10197753]
J Ethnopharmacol. 1999 Feb;64(2):173-7.
The phytochemical study using Virola michelli Heckel (Myristicaceae) leaves allowed the isolation of a flavone named titonine (7,4'-dimethoxy-3'-hydroxyflavone). Titonine was further submitted to methylation and acetylation reactions yielding a 7,3',4'-trimethoxyflavone and a 7,3'-dimethoxy-4'-acetylflavone, respectively. These compounds were evaluated for both anti-inflammatory and analgesic activity. The anti-inflammatory activity was evaluated in rats using the paw edema test with carrageenin, while the analgesic activity was determined in mouse using the writhing test method. The different animal groups were treated with three compounds (10 mg/kg -i.p.) thirty min prior to stimuli application. The inhibition levels obtained for each compound were 22, 41 and 68%, respectively. Using the writhing test, oral doses of 5, 10 and 15 mg/kg of natural flavone reduced the acetic acid-induced contortions in a dose-dependent manner.